Home        

 

Transwomen Pregnancy
[Part 1]

A young British transwoman: "I just want to have a baby"

8 January 2025:  I've discovered that there are many external links this page - which had some badly out of date content.  To avoid and minimise potential issues I have thus made some deletions and a few updates.  But I must emphasise that no medical advice or recommendations are being given, and I can't accept any liability for any decisions made based on its content.

Nomenclature:  There is currently (2020) intense pressure from LGBTI+ activists to avoid the use of words such as 'man' and 'woman' in a sexual and reproductive context.  This campaign has had great success, for example the Australia National University’s Gender Institute Handbook suggests that the word 'mother' be replaced by 'gestational parent', and 'father' by 'non-birthing parent'.   In the UK, the hugely influential charity Stonewall is requiring organisations (including schools and children's hospitals) to replace the words "boy" and "girl" with gender neutral terms such as "they".  However, the first version of this article was written in 2001 using traditional nomenclature - which I'm very reluctant to change.


Famous models and actresses often flaunt their pregnancy in the media
- unfortunately causing distress for some infertile women, including transwomen

The stress of being infertile, unable to get pregnant, not able to have babies negatively affects the mental health of tens, if not hundreds, of thousands of transwomen around the world.  For example, a 26-year-old transwoman in the USA with two adopted children was reported by the New York Times as: "craving to become pregnant ... I want the morning sickness, the backaches, the feet swelling. I want to feel the baby move.  That is something I’ve wanted for as long as I can remember."


Transgender woman Nicole Ferri, faking being pregnant in a short movie.
Until 2000 the idea of a genetic male (XY) being pregnant with a baby was still in the realm of science fiction and movie makers, but since then huge advances in female fertility treatment have made it a possibility for transsexual women who are prepared to undergo the required supportive hormone treatment and surgery. 

By 2000 two potentially viable medical procedures were identified to help cis-women without a functional uterus who were seeking to bear a baby (an estimated 1 in 500 women) - an ectopic pregnancy and a uterus transplant.  The procedures were also relevant to the rapidly increasing number of transwomen. 

Both procedures are discussed below, but only the later has so far emerged as practical. 

 

 

The Female Reproductive System

Before going any further it is necessary to consider the primary sexual organs needed to become "pregnant". The internal reproductive organs of a genetically XX woman include:

  • Ovaries - two glands that produce certain hormones and contain tissue sacs in which eggs develop
  • Fallopian tubes - two muscular channels that connect the ovaries with the uterus
  • Fimbria - finger-like projections at the opening of the fallopian tubes which sweep an egg released from an ovary into the tube where it can be fertilised by sperm before passage into the uterus 
  • Uterus (womb) - a hollow, muscular structure where a fertilised egg may settle and grow into a baby. 
  • Cervix - the lower part of the uterus that separates the body of the uterus from the vagina
  • Vagina - a muscular passage that connects the cervix with the external genital organs - one of which is a sensitive mound of tissue called the clitoris.  A male penis can penetrate the vagina to deposit typically a hundred million sperm at the entrance to cervix - from where an ever-smaller number swim onwards seeking an egg that just one can fertilise.

Additionally, women have a unique secondary sexual characteristic that for a million years was critical to the survival of a baby after birth - their breasts can lactate milk.

The Reproductive System of Transwomen

When high-quality gender confirmation and other feminisation surgery using modern techniques is combined with hormone treatment, the resulting external appearance - including the vulva - of many young XY male-to-female (MTF) transwomen is indistinguishable from that of a cis-woman at their peak fertile of age 20-30.  However, their neo-vagina does not lead on to a cervix.  Indeed, the cervix, uterus, ovaries, fimbria and fallopian tubes are all missing.  The reality is that a transwoman lacks the internal organs required to become pregnant.

 

The internal anatomy of a XX woman (left) compared with a XY transwoman after gender confirmation surgery.
Clearly the latter is missing many of the organs essential for pregnancy, with the neovagina not leading to a uterus.

There is currently no possibility that a transsexual women can be given the very complicated reproductive apparatus of a fertile woman.  Whilst the transplant of some individual organs (e.g. a heart or liver) has been possible for decades, the development or transplant of all the required organs and then establishing ovulation, periods and fertility is still far beyond the current state of medical science. 

Theoretically a dramatic hormonal and micro-surgery intervention on an embryo with male XY genes might result in the development of a baby with internal female sexual organs, but there is no obvious and ethical reason for doing this.

 

preg2.jpg (7937 bytes)Ectopic Pregnancy

Before 2000 an ectopic pregnancy - the development of the baby outside the uterus (womb) - seemed the most likely procedure for transgender women as it was medically simple because no transplants were required.

The technique involves attaching the foetus (the term used for developing babies under 8 weeks from conception) to the muscles inside the woman's abdomen, or an artificial womb formed from abdominal tissue.  Attachment to the bowel, with its good blood supply, is another attractive option, but perhaps the worst in terms of post-delivery trauma.

Unfortunately there are two big problems with the ectopic procedure:

  • There is a severe risk of a massive haemorrhage (copious bleeding from damaged blood vessels) if the ectopic placenta ruptures during pregnancy
  • Even if a viable baby is delivered surgically via a C-type section, it leaves a big problem regarding the implantation site.  Whilst the uterus is designed to cope with the eight-inch wound left when the placenta separates after birth; other organs have no such recovery mechanism. 

Natural occurrences of ectopic pregnancy do a occur, however they are considered very dangerous to the mother. 

By 2010 interest in this procedure had faded because of the risks that it involves for the patient, and the advances being made with uterus transplants.

 


Lili often modelled as a woman for paintings by his wife, Gerda Gottlieb.  Lili is here shown nude in  A Summer Evening, painted in 1927.

Uterus Transplant

The possibility of uterus transplants dates back to the origins sex-change surgery in the early 1930's.  Lili Elbe (born Einar Wegener) famously had the one of the earliest documented uterus implant operations in June 1931.  She sadly died just three months later from the complications.

After early failures, uterus implants were not regarded as a viable approach.  Experiments with dogs and baboons in the 1980's were unsuccessful as it was found to be very difficult to connect the required numerous blood vessels.  Pregnancy also puts huge strain on these connections, with very dangerous consequences if something goes wrong. 

Another major problem when transferring a uterus from one person to another is the likelihood of rejection, i.e. the transplanted womb is recognised by the implanted body as being foreign material and is "attacked".  This happened to Lili.  The risk of rejection can be reduced by taking drugs to suppress the immune system, but the drugs available in the 1980's were found to be harmful to early foetus development during a pregnancy and also increased the chance of developing cancer.  

However, in the 1990's the concept of a short-term (one to two years) uterus implant purely to bear a baby emerged.  Patients would still need to take immunosuppressant drugs to help stop their body immediately rejecting the uterus but researchers believed that the latest immunosuppressant drugs did not have any negative effects on a foetus.   After the woman had her child, the transplanted womb could be removed, avoiding long-term risks such as rejection and undesirable side effects from the drugs.  This idea started what effectively became a competition for the first successful pregnancy via a uterus transplant.

A paper published in the International Journal of Gynaecology and Obstetrics in March 2002 reported that that doctors in Saudi Arabia had performed the world's first womb transplant.  The operation was on a 26-year-old cis-woman who had lost her own womb because of excessive bleeding after childbirth.  The operation used the womb of a 46-year-old woman who needed a hysterectomy, and was performed on 6 April 2000.  It was initially deemed a success by the doctors, but the transplanted womb had to be removed 99 days later when scans revealed a blockage in one of the grafted vessels that cut off blood supply to the uterus.  However, the uterus did produce two hormone induced menstrual periods before it had to be removed.  

Swedish surgeons performing a uterus transplant operation in September 2012 Researchers then sought better ways of "plumbing in" the transplanted uterus than the Saudi's had used.  In June 2003 a Swedish team led by Dr Brännström of Sahlgrenska University in Gothenburg, announced a new technique where the transplanted womb is attached to two arteries and three veins on each side, with blood primarily coming from the external iliac artery.  It would also be attached to the vagina, and to the round and sacral ligaments to hold it in place, but not to the Fallopian tubes - if the woman has those.  The woman would not be able to conceive naturally, but would have to have IVF.  She would also have to give birth by Caesarean.  The technique was considered simpler and less risky than most transplant operations

In order to reduce the high risks, it was desirable that the uterus came from a woman with a close genetic match to the recipient in order to minimise the chance of rejection, as the womb does not deteriorate greatly from age it could come from a post-menopausal woman.  According to Dr Brännström "It could well be a relative.  You could get it from your mother.  You could give birth to a baby from the uterus that you yourself were birth from." 

Success


Malin Stenberg decided to go public about her experience when her son, Vincent, reached one year old.  She wanted to tell her story to give hope to others in the same situation.

In January 2014, Dr Mats Brannstrom revealed that the Gothenburg team had conducted nine womb transplants on women who were born without a uterus or had it removed because of cervical cancer.  On 5 October 2014, one of these women - Malin Stenberg - become the first in the world to have a baby after having a womb transplant.  The 36-year woman was born without a uterus, received a donated womb from a "post-menopause 60-year old friend" in a very long operation - it took a little over 10 hours to remove the uterus from the donor, and just under five hours to stitch it into the recipient.


Chelsea Jovanovich after a 12-hour uterus transplant operation in February 2020 at the University of Pennsylvania, USA. She gave birth to a baby boy, Telden, in May 2021.
Malin had already been taking hormones for a year to simulate her cycle and had her first period 43 days after the uterus transplant.  Doctors transferred an embryo into the uterus a year after her surgery. Three weeks later, a pregnancy test confirmed she was pregnant. At 31 weeks, she was admitted to hospital with preeclampsia, a serious medical condition that can develop during pregnancy, and her baby was delivered by C-section 16 hours later. She was discharged from hospital after three days, although the baby spent 16 days in the hospital’s neonatal unit.


No Longer Experimental
The success of the Swedish team led other hospitals to follow their procedure.  By 2024 135 uterus transplants had been performed globally at 25 hospitals, resulting in the birth of over 50 healthy babies.  Aggregated results show that about three quarters (73%) of uterus implants are successful, and nearly half (48%) of these eventually result in a baby. Whilst encouraging, for context, more than 25,000 kidney transplants were carried out in 2023 in the US alone.

If the woman is approved for the procedure, the process starts with creating an embryo using in vitro fertilization (IVF), in which the woman’s eggs are retrieved and fertilized with sperm. Next, a healthy uterus is transplanted into the patient. About six months after a successful uterus transplant, a single embryo is implanted into the uterus. If it leads to a successful pregnancy, the pregnancy is treated as high risk, and the baby will be delivered via Caesarean section, because women with UFI cannot delivery vaginally. Babies born from uterus transplant recipients tend to be born early, at about 35 weeks of gestation. Caring for these premature infants often requires a stay in a neonatal intensive care unit for several weeks. The entire process can take 2-5 years.

The woman must take immunosuppressive medications to prevent the body from rejecting the transplanted uterus. After the baby is born and if the woman does not want more children, the transplanted uterus is removed with a hysterectomy procedure, and the woman no longer needs to take anti-rejection medications.

 
Transwoman Emma Rose gained a lot publicity in 2024 when she started posting photos of herself apparently pregnant.  No birth has since been recorded and she was obviously wearing a fake silicone pregnancy belly.
Transwomen and Uterus Transplants

For a transsexual woman absolutely determined to start a family, a uterine transplant offers major advantages over surrogacy.  The transwoman is gestationally and socially clearly the mother.  She can also control lifestyle factors such as smoking and drinking alcohol, and she is the person who takes the health risks associated with every pregnancy.  But crucially, if the foetus is created using her frozen sperm, then she is genetically as close the baby as any cis-woman is of her baby.

In early November 2017, Dr Richard Paulson, President of the American Society for Reproductive Medicine, told a conference that uterus transplants had now become “mainstream” and that people who had undergone gender reassignment surgery would inevitably want to take advantage.  There was no anatomical reason why a uterus could not successfully be implanted into a transgender woman.  He said "You could do it tomorrow ... There would be  additional challenges, but I don’t see any obvious problem that would preclude it. ... I personally suspect there are going to be trans women who are going to want to have a uterus and will likely get the transplant."  Whilst men and women have a different shaped pelvis, he said that "there would nevertheless be room for an implanted womb."


It's rumoured that several Brazilian transwomen have received uterus transplants.
On 15 February 2019 the Daily Mail newspaper quoted
Christopher Inglefield, founder of the London Transgender Clinic, as saying "the procedure [for transgender women] is essentially identical to the one performed on women .. and it's important for trans females to be able to carry their own child."


After her GCS surgery in February 2021, 38-year old Jessica Alves claimed that she was having a uterus implant procedure in Brazil.

In February 2023 an article by Dr Flyckt and her colleagues at the Cleveland Clinic  said that it was now a matter of when the surgery was conducted, not if: "The first uterus transplant in a transgender female [will] take place within the next few years, if not sooner.

However not all doctors are quite so positive.   Dr J. Richard Smith of Imperial College London, who co-led the first uterus transplant performed in the UK believes that  “the transgender community have been given … false hope for responsible transplantation in the near future".  He explained that even cisgender women who need surgery to create a neovagina aren’t eligible for the uterus transplants his team are offering as part of a clinical study. They have an altered vaginal microbiome that appears to increase the risk of miscarriage.


An obvious pre-requisite for a uterus transplant is a donors womb.  A Hungarian newspaper claims that  "girls from the Hungarian countryside are selling their wombs to rich yuppies from New York".  Akció means 'for sale (special offer)'.
As of 2024 no transwoman has indeed had a successful uterus transplant and become pregnant - at least publicly.  No confirmed uterus transplant operation has been performed on a transsexual woman, but Brazil has a huge and unregulated "grey" market for cheap but often risky MTF feminisation surgery, possibly even including uterus transplants. The cost of this risky and very dubious procedure is rumoured to be about $45,000, including a payment of just $10,000 to the uterus donor.

Ethical and Other Considerations

An unusual aspect about uterus transplants is that currently they’re meant to be temporary. Typically a woman receives a uterus via transplantation, its implanted with an embryo created via in vitro fertilisation (IVF), she gives birth via caesarean section, and then has a hysterectomy to remove the uterus. This is very different from other more routine organ transplants like heart or liver transplants, which are intended to be permanent once they’re put into the recipient. A uterus transplant is also not a lifesaving procedure in the same way a heart transplant would be.

There are also questions concerning donation and the assignment of organs - for example, what if a donor specifies that they only want to donate their uterus to a cis-woman, and not to a transgender woman?  There is then an overlap with legal consideration as withholding a uterus to a transgender woman could breach anti-discrimination laws. In the UK the Human Fertilisation and Embryology Act 2008, states that an embryo has to be implanted into a "woman", it would thus be illegal for an IVF clinic in the UK to create an embryo for the purpose of implanting it in a transwoman with a uterus transplant in order to make her pregnant.

However the later Equality Act 2010 superseds this by clarifying that for legal purposes a transwoman is a woman, as long as they've gone through the legal process of being recognised as a woman. It would thus be illegal to refuse to a uterus transplant to a transgender woman solely because of they are transgender.

Chloe Romanis, an Associate Professor in Biolaw at Durham University, Laura O’Donovan, a research associate at Lancaster University and Dr  Hammond-Browning at Cardiff Law School, make several important points regarding transwomen having uterus implants which I have tried to aggregate these:
  • Is there a right to gestate?
  • Is there a clear reproductive purpose?
  • Is it just a quality of life enhancing transplant, as opposed to being lifesaving?
  • How do you clinically decide whose need is more significant? A cis-woman born without a uterus or who's had a hysterectomy after cancer, or a transwoman?
  • Will the transplant actually consolidate their female identity?
  •  Who should pay for this expensive procedure?

Ayana Tsubaki and Jenny Hiloudaki - post-SRS transsexual women 'photo-shopped' as pregnant for advertisements.
The Montreal Criteria

Dr Brännström believes that it might be possible to transplant a womb into transsexual women, allowing them to become pregnant with using donated eggs, though anatomical barriers would have to be overcome.  "It should be technically possible, but I don't know if it's ethical." 

The crucial caveat is a reference to the Montreal Criteria for the Ethical Feasibility of Uterine Transplantation.  It's an ethical framework published in 2012 designed to assess whether a woman could be considered as a transplant candidate.  Among the list of qualifying criteria is the requirement that the uterus recipient should be a "genetic female of reproductive age". Whilst surgeons and medical teams are reluctant to risk not complying with a widely accepted ethical standard, the Montreal Criteria has become controversial as it prevents transwomen having a uterus transplant.  There has thus become a campaign, led by Dr. Jacques Balayla from the McGill University, to remove the reference "genetic female" from the Montreal Criteria.  He states in an interview dated March 2021 that:

“A woman who is born without a uterus and a man who transitions into a woman because of gender dysphoria have a similar claim to maternity if we consider them to have equivalent rights to fulfil the reproductive potential of their gender.  While still theoretical, it appears that implantation of a donated uterus and gestation in the body of a transgender individual should pose no physiological barrier if various conditions are met."

However, there seems to be no likelihood that the criteria will be amended in the near future, so any surgeon or hospital conducting a uterus transplant on a transwoman will be on a risky solo run.
 

Detailed Procedure

Assuming that the mother and her medical team have determined that the risks are acceptable, the key steps for a transwoman to become pregnant are:


Step 1: Gender Reassignment Surgery
Sperm is donated and frozen before gender reassignment surgery is conducted, removing the testes and creating a neovagina.


Step 2: Donor Hysterectomy

The uterus is removed from a donor - ideally a close female relative of the patient but possibly a deceased woman.  Only the uterus is removed, not the ovaries and fallopian tubes.


Step 3: Transplant
The uterus is transplanted into the abdomen of the transwoman and its entrance connected to the neovagina.


Step 4: Connect Blood Vessels
In possibly the most critical step, the uterus is connected to the patients' blood vessels, in particular the descending aorta and the iliac artery.


Step 5: Healing
The patients body is allowed to heal and immnosuppressant drugs are prescribed to prevent counter rejection whilst the implant establishes.


Step 6: Hormonal Preparation
If all has gone well after 3-4 months of healing, hormones are administered to simulate periods and make the uterus receptive to pregnancy by growing a endometrial lining, also known as the uterine lining, in preparation for an embryo.


ultrasound.jpg (9811 bytes)Step 7: In Vitro Fertilisation
IVF techniques are used to fertilise eggs taken from a cis-woman donor, preferably a close female relative (mother or sister) of the father.  Ideally the sperm is from a sample provided by the patient before her GCS.


Step 8: Establishment of the Foetus

If a pregnancy does result, the first trimester is critical, with a high probability of a miscarriage.  The developing foetus will be carefully monitored development, i.e. foetal heart monitoring, chronic villus sampling, ultrasound scanning, and a constant watch kept over the mother's health. Once the embryo is established, hormone treatment can be reduced because the pregnancy itself will take over. The placenta and embryo secrete sufficient natural hormones to maintain growth and development.


Step 9: Growth of the Baby
Self evidentally this step involves the development of the baby. The mother typically becomes aware of its movements between 16 and 24 weeks of pregnancy.


cesarian.jpg (11903 bytes)Step 10: Delivery
The delivery will require surgery (Caesarean section) to remove the baby and also the placenta.  Manual removal of the placenta is essential as a natural "afterbirth" is improbable, even if the uterus has been connected to the neovagina.


Step 11. Uterus Removal
Unless the implanted uterus has an exceptional tissue match to the patient (typically because it was donated by a mother or sister) and there are also no indications of rejection, it will need to be removed after 2-3 years. A maximum of two pregnancies is thus possible
.

 

 

 

 

The baby will need to be delivered by Caesarean section because the transwoman lacks the organs and muscles involved in natural contractions and labour, but this is minor obstacle given that about quarter of all babies are already born by this method in Western Europe, and a third in the USA.  

The diagram above shows the result of a theoretical uterus transplant procedure for a trans-woman.  The transplant includes the cuff of the donors vagina, which is shown connected to a neo-vaginal canal probably constructed from penile skin and tissue - this is very useful for access to the uterus and clearing hormone induced menstrual flows.  Obviously there are no ovaries and the uterine tubes have been truncated.  After surgery there would be a c.12 week recovery period and the patient would require immunosuppressant drugs so that her body wouldn’t reject the new organ. The patient may need to wait a year before doctors will risk transplanting embryos into the new uterus, carefully prepared with hormones.  If all goes well, the patient will become pregnant and carry her baby to term, for birth by C-section. 

These images of Argentinean television celebrity Florencia de la Vega (Flor) provide a look into the near future.  She was born Roberto Carlos Trinidad in 1995 and transitioned age 16.  She thereafter worked as a showgirl and TV actress, and probably had SRS in 2010.  In early 2011 she married Pablo Goycochea, age 36.  Soon after, in August 2011, they announced the birth of twin babies - a boy and a girl.  The front cover of Gente magazine shows Flor with the newborn twins whilst inside there was a carefully posed picture with her belly emphasised, which could easily be mistaken for showing her pregnant.  Whilst the supporting article repeatedly referred to Flora as the twins mother, it never explicitly states that she had been pregnant and given birth to them.  In fact the twins are the result of her husband's sperm impregnating a surrogate mother.  The magazine continues to regularly feature Flor and her children.

Genetic Parentage


Anne Jakrajutatip is a transwoman and the mother of two children conceived with a surrogate German woman using her sperm taken just before her SRS age 39.
For perhaps a millions of years, human embryos have always been formed by the union of a sperm (supplied by a genetically XY male) and an egg or ovum (supplied by a XX female).  Both the sperm and the ovum provide DNA, but the ovum also provides a “house” in which the embryo grows during the early stages of development.  An ovum is therefore absolutely essential for reproduction.

A transwoman lacks the ovaries needed to produce an ovum containing her genes, and more specifically 23 of her chromosones.  Thus, until the 2000's the primary method for a transwoman to gain a baby was having the egg of a surrogate mother being fertilised by sperm from her husband or partner, and the resulting baby being adopted after its birth.  Clearly this approach is somewhat unsatisfactory for the transsexual woman as she has no genetic relationship with her baby.


Many transitioning transwomen now freeze a sample of their sperm before "bottom surgery".  This can later be used for IVF.  Pictured are Taylor Vanmalsen, her cis-female partner Sarah, and their baby Valerie.
However, there are now several options that a transsexual woman can take in order to be genetically related to her baby - whether born by herself or a surrogate mother.  These usually involve having frozen a sample of sperm before gender confirmation surgery.  A few examples include:

  1. The most extreme option is that unfrozen sperm is used to fertilise a donated ovum (egg) from her mother or a sister.  The transwoman would then potentially share an extraordinary 75% of her chromosomes with the baby.  This option is ethically dubious, but few countries currently have laws that address this possibility. 

  2. Unfrozen sperm is used for IVF to fertilise the egg of a female partner.  They will both have the normal 50% shared chromosomes with the baby.

  3. Unfrozen sperm is used to fertilise a close female relative of her husband/partner - such as a sister or even mother.  The transwoman would then have normal 50% shared chromosomes with the baby, and her husband/partner 25%.

  4. The transwoman's sister or mother donates an ovum for fertilisation by sperm from the father and gestation by a surrogate - in this instance the transsexual mother will share 25% of her babies genes, and her husband/partner a normal 50%.

Also, for many years there has been speculation about potential new options which use a cloning technique called "membrane fusion" to create a fertilisable egg.  A surprisingly simple technique has now emerged.  Basically, a woman donates an ovum egg.  The nucleus, containing this woman's DNA, is removed, and a nucleus with genes (including two paired sets of chromosomes - totally 26) extracted from one of the transwoman's skin cells is put into its place. The ovum realises that it has too many chromosomes and discards half of them, thus creating an unfertilised egg with just one set of 13 chromosomes.  Using standard IVF techniques the new ovum can then be fertilised by the father's sperm and implanted into the uterus of a surrogate mother.  Both the mother and her husband/partner will have a a normal 50% share of the baby's gene's. 

 

 


Jennifer Dinge (USA) was born without a uterus due to having MRKH syndrome.  After a uterus transplant in 2016 she successfully had two babies.

Transwomen Still Face Major Obstacles

When the first version of this page was drafted in 2001, the idea of a genetically XY male-to-female transsexual becoming pregnant was still close to science fiction.  Over 20 years later it's clear that all the major medical barriers have now been overcome.  Indeed, it is quite possible that somewhere in the world (most probably in Brazil) a transwoman has already quietly given birth.

 

"I've just got a text saying I've been accepted by the university's uterus transplant programme. I might be the first transwoman to have a baby!"
However, transwomen still face significant barriers to having a baby. As noted above, the most significant problem is the out-dated Montreal Criteria.  Another problem is time and risks.  For example, after she married in 2007, 32-year-old South Korean singer and transwoman Harisu frequently expressed her desire to have a baby.  In 2015 she was accepted for a uterus transplant by the Daejeon St. Mary's Hospital in Seoul but as she progressed through the program her husband became increasingly concerned about the risks his now 40+ wife faced.  She eventually accepted that spending a year or more either in hospital or under close medical supervision was simply not practical for her.

TThe next problem is cost.  Uterus transplants are only just moving from research to mainstream, and as such are still being hugely subsidised.   Although uterus transplants are starting to become an accepted medical procedure, few public health services or health insurance policies are likely to cover them due to the very high cost, indeed health insurance policies are starting to specifically exclude it.  The UK's NHS estimated in 2020 that prospective "routine" uterus transplants procedures involving a cis-woman would cost about £50,000, however this was just for the two operations (donor and recipient) plus immediate pre- and post-operative care.  Other estimates are even higher, in 2019 the American based UTX group estimated $200,000 for a uterus transplant, whilst an article in PubMed estimated €50,000 to €100,000 (mean €74,000) in Year 2020 values per uterus transplantation.

The total medical costs over 3+ years for a transgender woman to go through all stages from gender confirmation surgery, uterus transplant, pregnancy, birth and finally uterus removal could easily be £/€/$ 1 million.  And that is just the direct medical expenses, without even including other factors such as loss of earnings.  Pregnancy and motherhood seems likely for many years to be a privilege reserved for transwomen with substantial personal wealth or a rich husband. 

 Part 2 of "Transsexual Pregnancy" Beauty - Part 2
 


PE02072A.gif (2034 bytes) Back to Articles


(c) 2000 - 2024 Annie Richards

Please send any comments, feedback or additions to:

Last updated: 17 February, 2023